Skip to main content
Premium Trial:

Request an Annual Quote

Embark Scientific Buys Mouse Genotyping Assets from MendelWorks

NEW YORK (GenomeWeb News) – Genomics services company Embark Scientific has purchased mouse genotyping assets from MendelWorks, an Identigene spin-off, for an undisclosed sum, Embark said earlier this week.
 
Austin, Tex.-based Embark said the deal will help increase its mouse genotyping capacity and its animal genotyping market share. The added capacity includes PCR and real-time PCR-based genotyping, gene expression, and RNA expression analysis, the company said.
 
In addition to mouse genotyping, Embark offers DNA sequencing, RNA expression analysis, assay development, and lab consulting services to clients in government, academia, and in industry.
 
Financial terms of the agreement were not released.

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.